Fortress Biotech (FBIO) Shares Outstanding (Diluted) (2018 - 2026)
Powered by 
Analysis
Fortress Biotech (FBIO) Shares Outstanding (Diluted) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | 31.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.79 Mn |
| Dec 31, 2025 | 27.90 Mn |
| Sep 30, 2025 | 33.10 Mn |
| Jun 30, 2025 | 29.82 Mn |
| Mar 31, 2025 | 26.45 Mn |
| Dec 31, 2024 | 20.78 Mn |
| Sep 30, 2024 | 19.70 Mn |
| Jun 30, 2024 | 18.32 Mn |
| Mar 31, 2024 | 17.15 Mn |
| Dec 31, 2023 | 8.11 Mn |
| Sep 30, 2023 | 7.50 Mn |
| Jun 30, 2023 | 7.38 Mn |
| Mar 31, 2023 | 6.79 Mn |
| Dec 31, 2022 | 5.93 Mn |
| Sep 30, 2022 | 5.96 Mn |
| Jun 30, 2022 | 5.92 Mn |
| Mar 31, 2022 | 5.75 Mn |
| Dec 31, 2021 | 5.45 Mn |
| Sep 30, 2021 | 5.42 Mn |
| Jun 30, 2021 | 5.40 Mn |